Pictet Asset Management Sa Nevro Corp Transaction History

Pictet Asset Management Sa

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$36.43 - $49.4 $345,064 - $467,916	9,472 Added 3.78%	260,306 $10.3 Million
Q3 2022 Nov 14, 2022	BUY	$40.66 - $53.03 $26,428 - $34,469	650 Added 0.26%	250,834 $11.7 Million
Q2 2022 Aug 09, 2022	SELL	$40.85 - $77.67 $1.99 Million - $3.78 Million	-48,715 Reduced 16.3%	250,184 $11 Million
Q1 2022 May 13, 2022	BUY	$59.95 - $92.06 $4.07 Million - $6.24 Million	67,826 Added 29.35%	298,899 $21.6 Million
Q4 2021 Feb 10, 2022	SELL	$81.07 - $121.29 $267,936 - $400,863	-3,305 Reduced 1.41%	231,073 $18.7 Million
Q3 2021 Nov 12, 2021	BUY	$101.99 - $166.36 $23.9 Million - $39 Million	234,378 New	234,378 $27.3 Million

151

39.3M

67.9K

1.59M

Ticker NVRO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,387,800
Market Cap $133M
Description
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...

Get notified when there are updates to the investment portfolio of Pictet Asset Management Sa, based on Form 13F filings with the SEC.

Stay updated on Pictet Asset Management Sa with notifications on news.